<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02599155</url>
  </required_header>
  <id_info>
    <org_study_id>H1507-061-687</org_study_id>
    <nct_id>NCT02599155</nct_id>
  </id_info>
  <brief_title>The Effect of the Hydroxyethyl Starch on Kidney Injury in Pediatric Cardiac Surgery</brief_title>
  <official_title>The Effect of the Hydroxyethyl Starch on Kidney Injury in Pediatric Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigator will evaluate the influence of colloid administration on postoperative acute
      kidney injury in pediatric patients undergoing cardiac surgery under cardiopulmonary bypass.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigator will randomly divide pediatric patients aged less than 7 years old into
      crystalloid and colloid groups. Crystalloid group receive only crystalloid, and colloid group
      receive hydroxyethyl starch (HES, 130/0.4). The maximum volume of HES is limited less than 30
      ml/kg. The same transfusion protocol will be applied in both groups. From the day of
      operation to postoperative 7 days, glomerular filtration rate (GFR), serum creatinin level
      (Cr) will be checked. Acute kidney injury (AKI) is defined when there is more than 50%
      increase in Cr when compared to baseline level. The investigator will compare the clinical
      outcomes including AKI between two groups.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Acute Kidney Injury</measure>
    <time_frame>From the day of surgery to postoperative 7 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood loss</measure>
    <time_frame>From the day of surgery to postoperative 7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transfusion amount</measure>
    <time_frame>From the day of surgery to postoperative 7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mechanical ventilation time</measure>
    <time_frame>From the day of surgery to postoperative 7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of ICU stay</measure>
    <time_frame>From the day of surgery to postoperative 7 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>Crystalloid group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Crystalloid group receive only crystalloid for intravenous volume expansion. The same transfusion protocol is applied in both groups.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Colloid group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Colloid group receive colloid preferentially for intravenous volume expansion, until 30 ml/kg. The same transfusion protocol is applied in both groups.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Crystalloid</intervention_name>
    <description>normal saline administration for volume expansion in hypovolemic status</description>
    <arm_group_label>Crystalloid group</arm_group_label>
    <other_name>normal saline</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Colloid</intervention_name>
    <description>HES 130/0.4 administration for volume expansion in hypovolemic status</description>
    <arm_group_label>Colloid group</arm_group_label>
    <other_name>HES 130/0.4</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children aged less than 7 years old

          -  American Society of Anesthesiology (ASA) physical status 1-3

        Exclusion Criteria:

          -  Preoperative creatinine &gt; 1.5mg/dl

          -  History of dialysis

          -  Liver function abnormality

          -  Diabetes Mellitus

          -  History of allergic reaction

          -  Coagulation abnormality
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>7 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jin-Tae Kim, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul national university hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2015</study_first_submitted>
  <study_first_submitted_qc>November 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 6, 2015</study_first_posted>
  <last_update_submitted>June 22, 2017</last_update_submitted>
  <last_update_submitted_qc>June 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jin-Tae Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>crystalloid</keyword>
  <keyword>colloid</keyword>
  <keyword>children</keyword>
  <keyword>infant</keyword>
  <keyword>cardiac surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

